Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
| Business Activity | PASS |
| Debt Ratio | N/A |
| Cash Ratio | N/A |
| Receivables Ratio | N/A |
| Revenue Ratio (0.00%) | PASS |
| Overall | PASS |
$2.4B
11.21
2.163
7
$295.4M
$208.2M
1.50
5.62
0.1%
624
| Shares | Cost | Profit to Target | R:R |
|---|---|---|---|
| To Consensus ($20.14, 7 analysts) | |||
| 10 | $138.40 | +$63.00 (46%) | 3.0R |
| 50 | $692.00 | +$315.00 (46%) | 3.0R |
| 100 | $1,384.00 | +$630.00 (46%) | 3.0R |
- High beta (2.16) — amplifies market moves by 2.16x
- Elevated short interest (5.62 days to cover)
A single score combining all analytical layers below. A is strongest, D is weakest.
How much could this ticker lose on a bad day? These metrics measure worst-case scenarios from historical data.
Based on 10,000 simulated price paths, here is the probability of where this ticker could be in 30, 60, and 90 days.
What direction is this ticker actually moving, filtered through noise? Is it speeding up or slowing down?
Classic chart signals that institutional traders monitor. Golden Cross is bullish, Death Cross is bearish.
Is this company financially sound? The Z-Score measures bankruptcy risk. The F-Score measures fundamental strength.
These tickers tend to move together (positive) or in opposite directions (negative). Useful for portfolio diversification.
| Ticker | Correlation |
|---|---|
| ARKG | 0.656 |
| IWM | 0.482 |
| TWST | 0.481 |
| ARKK | 0.474 |
| BEAM | 0.452 |
| Ticker | Correlation |
|---|---|
| ED | -0.159 |
| BAES.L | -0.156 |
| KR | -0.144 |
| 1724.KL | -0.139 |
| CBOE | -0.138 |
Does this ticker have consistent patterns on certain days or months? Historical tendencies, not guarantees.
How does this ticker's recent performance compare to the entire universe? Ranked across 1, 3, 6, and 12-month returns.